The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from Quebec

Figure 5

Type of treatment previously received or currently being received for treating HAE. IV, intravenous; pdC1-INH, plasma-derived C1 inhibitor; SC, subcutaneous.